BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30971080)

  • 21. Increasing prevalence of hypertension among HIV-positive and negative adults in Senegal, West Africa, 1994-2015.
    Benzekri NA; Seydi M; N Doye I; Toure M; Sy MP; Kiviat NB; Sow PS; Gottlieb GS; Hawes SE
    PLoS One; 2018; 13(12):e0208635. PubMed ID: 30596667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of self diagnosis of high blood pressure in a sample of the Spanish EPIC cohort: overall agreement and predictive values. EPIC Group of Spain.
    Tormo MJ; Navarro C; Chirlaque MD; Barber X
    J Epidemiol Community Health; 2000 Mar; 54(3):221-6. PubMed ID: 10746117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of arterial hypertension in the Krasnoyarsk Krai (Siberia, Russia).
    Artyukhov IP; Grinshtein YI; Petrova MM; Shabalin VV; Ruf RR
    BMC Cardiovasc Disord; 2017 May; 17(1):138. PubMed ID: 28549412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of HTN in Iran: Meta-analysis of Published Studies in 2004-2018.
    Oori MJ; Mohammadi F; Norozi K; Fallahi-Khoshknab M; Ebadi A; Gheshlagh RG
    Curr Hypertens Rev; 2019; 15(2):113-122. PubMed ID: 30657043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of routine care self-reported and biometrical data on hypertension and diabetes: results of the Utrecht Health Project.
    Molenaar EA; Van Ameijden EJ; Grobbee DE; Numans ME
    Eur J Public Health; 2007 Apr; 17(2):199-205. PubMed ID: 16887835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence, Awareness, Treatment, and Control of High Blood Pressure: A Population-Based Survey in Thai Nguyen, Vietnam.
    Ha DA; Goldberg RJ; Allison JJ; Chu TH; Nguyen HL
    PLoS One; 2013; 8(6):e66792. PubMed ID: 23826134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigating the prevalence of hypertension and its associated risk factors in a population-based study: Fasa PERSIAN COHORT data.
    Bijani M; Parvizi S; Dehghan A; Sedigh-Rahimabadi M; Rostami-Chijan M; Kazemi M; Naghizadeh MM; Ghaemi A; Homayounfar R; Farjam M
    BMC Cardiovasc Disord; 2020 Dec; 20(1):503. PubMed ID: 33256609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and treatment of hypertension in urban and riverside areas in Porto Velho, the Brazilian Amazon.
    Almeida RC; Dias DJ; Deguchi KT; Spesia CH; Coelho OR
    Postgrad Med; 2015 Jan; 127(1):66-72. PubMed ID: 25526235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Untreated hypertension and the emergency department: a chance to intervene?
    Umscheid CA; Maguire MG; Pines JM; Everett WW; Baren JM; Townsend RR; Mines D; Szyld D; Gross R
    Acad Emerg Med; 2008 Jun; 15(6):529-36. PubMed ID: 18616438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prevalence of erectile dysfunction among hypertensive and prehypertensive men aged 25-40 years.
    Heruti RJ; Sharabi Y; Arbel Y; Shochat T; Swartzon M; Brenner G; Justo D
    J Sex Med; 2007 May; 4(3):596-601. PubMed ID: 17498098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progression from optimal blood glucose and pre-diabetes to type 2 diabetes in a high risk population with or without hypertension in Isfahan, Iran.
    Janghorbani M; Amini M
    Diabetes Res Clin Pract; 2015 Jun; 108(3):414-22. PubMed ID: 25814432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A retrospective analysis of the prevalence and treatment of hypertension and dyslipidemia in Southwestern Ontario, Canada.
    Petrella RJ; Merikle E
    Clin Ther; 2008 Jun; 30(6):1145-54. PubMed ID: 18640470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validity Assessment of Self-reported Medication Use for Hypertension, Diabetes, and Dyslipidemia in a Pharmacoepidemiologic Study by Comparison With Health Insurance Claims.
    Matsumoto M; Harada S; Iida M; Kato S; Sata M; Hirata A; Kuwabara K; Takeuchi A; Sugiyama D; Okamura T; Takebayashi T
    J Epidemiol; 2021 Sep; 31(9):495-502. PubMed ID: 33361656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of a pro-inflammatory diet with type 2 diabetes and hypertension: results from the Ravansar non-communicable diseases cohort study.
    Jam SA; Rezaeian S; Najafi F; Hamzeh B; Shakiba E; Moradinazar M; Darbandi M; Hichi F; Eghtesad S; Pasdar Y
    Arch Public Health; 2022 Mar; 80(1):102. PubMed ID: 35361279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and incidence of pre-hypertension and hypertension (awareness/control) in Iran: findings from Kerman coronary artery diseases risk factors study 2 (KERCADRS).
    Najafipour H; Nasri HR; Rostamzadeh F; Amirzadeh R; Shadkam M; Mirzazadeh A
    J Hum Hypertens; 2022 May; 36(5):461-472. PubMed ID: 32929131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accuracy of self-reported hypertension: a systematic review and meta-analysis.
    Gonçalves VSS; Andrade KRC; Carvalho KMB; Silva MT; Pereira MG; Galvao TF
    J Hypertens; 2018 May; 36(5):970-978. PubMed ID: 29232280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and predictors of hypertension self-care practice in primary health-care facilities in Southern Tunisia.
    Ketata N; Ben Ayed H; Ben Hmida M; Abdelhedi Z; Ben Jemaa M; Trigui M; Maamri H; Yaich S; Kassis M; Feki H; Damak J
    J Med Vasc; 2021 Apr; 46(2):72-79. PubMed ID: 33752849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Self-reported hypertension: validation in a representative cross-sectional survey].
    Chrestani MA; Santos Ida S; Matijasevich AM
    Cad Saude Publica; 2009 Nov; 25(11):2395-406. PubMed ID: 19936478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of hypertension care and control among peri-urban Black South Africans: the HiHi study.
    Dennison CR; Peer N; Steyn K; Levitt NS; Hill MN
    Ethn Dis; 2007; 17(3):484-91. PubMed ID: 17985502
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.